Prevention strategies for chemotherapy-induced hand–foot syndrome: a systematic review and meta-analysis of prospective randomised trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-014-2129-z.pdf
Reference42 articles.
1. Almeida da Cruz L, Hoff PM, Ferrari CL, Riechelmann RS (2012) Unilateral hand–foot syndrome: does it take sides? Case report and literature review. Clin Colorectal Cancer 11:82–84
2. Hoesly FJ, Baker SG, Gunawardane ND, Cotliar JA (2011) Capecitabine-induced hand–foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature. Arch Dermatol 147:1418–1423
3. Belum VR, Wu S, Lacouture ME (2013) Risk of hand–foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis. Invest New Drugs 31:1078–1086
4. Fischer A, Wu S, Ho AL, Lacouture ME (2013) The risk of hand–foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysis. Invest New Drugs 31:787–797
5. Balagula Y, Wu S, Su X et al (2012) The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis. Invest New Drugs 30:1773–1781
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome;2024-08-09
2. A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Topical Urea for Secondary Prophylaxis of Hand Foot Skin Reaction in Renal Cell Cancer Patients on Sunitinib Therapy;Clinical Genitourinary Cancer;2024-06
3. Imrecoxib: Advances in Pharmacology and Therapeutics;Drug Design, Development and Therapy;2024-05
4. Capecitabine-induced hand foot syndrome: a brief look at possible pathways that may be associated with inflammation;ODÜ Tıp Dergisi;2024-04-30
5. Challenges and Opportunities for Celecoxib Repurposing;Pharmaceutical Research;2023-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3